Rapid actions of androgens

Frontiers in Neuroendocrinology

Volumn 29, Issue 2, 2008, Pages 182-198

  Michels, Guido ^a   Hoppe, Uta C ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Acute actions of androgens; Androgens; Non genomic effects of androgens; Testosterone

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CALCIUM; CELL NUCLEUS RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; G PROTEIN COUPLED RECEPTOR; ION CHANNEL; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEOTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; PROTEIN KINASE C; SEX HORMONE BINDING GLOBULIN; TRANSCRIPTION FACTOR;

BIOLOGICAL ACTIVITY; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CELL MEMBRANE; CELL SURFACE; CROSS LINKING; CYTOPLASM; ENZYME ACTIVATION; GENE EXPRESSION; GENOMICS; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; INTRACELLULAR SPACE; ION TRANSPORT; MODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROGENS; ANIMALS; CALCIUM; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HETEROTRIMERIC GTP-BINDING PROTEINS; HOMEOSTASIS; HUMANS; ION CHANNELS; ION TRANSPORT; MEMBRANE LIPIDS; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; PROTEIN KINASE C; RECEPTORS, ANDROGEN; SECOND MESSENGER SYSTEMS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 41549099554     PISSN: 00913022     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yfrne.2007.08.004     Document Type: Review

References (221)

1. Agapova O.A., Malone P.E., and Hernandez M.R. A neuroactive steroid 5alpha-androstane-3alpha,17beta-diol regulates androgen receptor level in astrocytes. J. Neurochem. 98 (2006) 355-363
2. Aikey J.L., Nyby J.G., Anmuth D.M., and James P.J. Testosterone rapidly reduces anxiety in male house mice (Mus musculus). Horm. Behav. 42 (2002) 448-460
3. Alexandersen P., Haarbo J., Byrjalsen I., Lawaetz H., and Christiansen C. Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ. Res. 84 (1999) 813-819
4. Avvakumov G.V., Survilo L.I., and Strel'chenok O.A. Interaction of blood sex steroid-binding globulin with cell membranes of human decidual tissue. Biokhimiia 50 (1985) 1155-1161
5. Bai C.X., Kurokawa J., Tamagawa M., Nakaya H., and Furukawa T. Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation 112 (2005) 1701-1710
6. Becchis M., Sullivan P.M., Ordronneau P., Petrusz P., and Joseph D.R. Distribution of immunoreactive androgen-binding protein/sex hormone-binding globulin in tissues of the fetal rat. Steroids 61 (1996) 392-400
7. Benten W.P., Guo Z., Krucken J., and Wunderlich F. Rapid effects of androgens in macrophages. Steroids 69 (2004) 585-590
8. Benten W.P., Lieberherr M., Giese G., Wrehlke C., Stamm O., Sekeris C.E., Mossmann H., and Wunderlich F. Functional testosterone receptors in plasma membranes of T cells. FASEB J. 13 (1999) 123-133
9. 2+ influx via non-genomic surface receptors in activated T cells. FEBS Lett. 407 (1997) 211-214
10. Benten W.P., Lieberherr M., Stamm O., Wrehlke C., Guo Z., and Wunderlich F. Testosterone signaling through internalizable surface receptors in androgen receptor-free macrophages. Mol. Biol. Cell 10 (1999) 3113-3123
11. Berridge M.J., Bootman M.D., and Lipp P. Calcium-a life and death signal. Nature 395 (1998) 645-648
12. Beullens M., Van Eynde A., Bollen M., and Stalmans W. Inactivation of nuclear inhibitory polypeptides of protein phosphatase-1 (NIPP-1) by protein kinase A. J. Biol. Chem. 268 (1993) 13172-13177
13. Bidoggia H., Maciel J.P., Capalozza N., Mosca S., Blaksley E.J., Valverde E., Bertran G., Arini P., Biagetti M.O., and Quinteiro R.A. Sex differences on the electrocardiographic pattern of cardiac repolarization: possible role of testosterone. Am. Heart J. 140 (2000) 678-683
14. Black B.E., Vitto M.J., Gioeli D., Spencer A., Afshar N., Conaway M.R., Weber M.J., and Paschal B.M. Transient, ligand-dependent arrest of the androgen receptor in subnuclear foci alters phosphorylation and coactivator interactions. Mol. Endocrinol. 18 (2004) 834-850
15. Blok L.J., de Ruiter P.E., and Brinkmann A.O. Androgen receptor phosphorylation. Endocr. Res. 22 (1996) 197-219
16. Blok L.J., de Ruiter P.E., and Brinkmann A.O. Forskolin-induced dephosphorylation of the androgen receptor impairs ligand binding. Biochemistry 37 (1998) 3850-3857
17. Bonaccorsi L., Muratori M., Carloni V., Marchiani S., Formigli L., Forti G., and Baldi E. The androgen receptor associates with the epidermal growth factor receptor in androgen-sensitive prostate cancer cells. Steroids 69 (2004) 549-552
18. Bos J.L. All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral. EMBO J. 17 (1998) 6776-6782
19. Brazil D.P., Park J., and Hemmings B.A. PKB binding proteins. Getting in on the Akt. Cell 111 (2002) 293-303
20. Burton R.M., and Westphal U. Steroid hormone-binding proteins in blood plasma. Metabolism 21 (1972) 253-276
21. 2+ stimulates the binding to androgen receptors in platelets. Steroids 69 (2004) 767-772
22. Caldwell J.D., Song Y., Englof I., Hofle S., Key M., and Morris M. 5alpha-Reduced androgens block estradiol-BSA-stimulated release of oxytocin. Brain Res. 976 (2003) 259-261
23. Castoria G., Barone M.V., Di Domenico M., Bilancio A., Ametrano D., Migliaccio A., and Auricchio F. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J. 18 (1999) 2500-2510
24. Castoria G., Lombardi M., Barone M.V., Bilancio A., Di Domenico M., Bottero D., Vitale F., Migliaccio A., and Auricchio F. Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. J. Cell Biol. 161 (2003) 547-556
25. Castoria G., Lombardi M., Barone M.V., Bilancio A., Di Domenico M., De Falco A., Varricchio L., Bottero D., Nanayakkara M., Migliaccio A., and Auricchio F. Rapid signalling pathway activation by androgens in epithelial and stromal cells. Steroids 69 (2004) 517-522
26. Chan T.O., Rodeck U., Chan A.M., Kimmelman A.C., Rittenhouse S.E., Panayotou G., and Tsichlis P.N. Small GTPases and tyrosine kinases coregulate a molecular switch in the phosphoinositide 3-kinase regulatory subunit. Cancer Cell 1 (2002) 181-191
27. Charalampopoulos I., Alexaki V.I., Lazaridis I., Dermitzaki E., Avlonitis N., Tsatsanis C., Calogeropoulou T., Margioris A.N., Castanas E., Gravanis A., and protein-associated G. specific membrane binding sites mediate the neuroprotective effect of dehydroepiandrosterone. FASEB J. 20 (2006) 577-579
28. Chen S., Xu Y., Yuan X., Bubley G.J., and Balk S.P. Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1. Proc. Natl. Acad. Sci. USA 103 (2006) 15969-15974
29. Cheng J., Watkins S.C., and Walker W.H. Testosterone activates mitogen-activated protein kinase via Src kinase and the epidermal growth factor receptor in sertoli cells. Endocrinology 148 (2007) 2066-2074
30. Cho J.J., Cadet P., Salamon E., Mantione K., and Stefano G.B. The nongenomic protective effects of estrogen on the male cardiovascular system: clinical and therapeutic implications in aging men. Med. Sci. Monit. 9 (2003) RA63-RA68
31. Chou T.M., Sudhir K., Hutchison S.J., Ko E., Amidon T.M., Collins P., and Chatterjee K. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation 94 (1996) 2614-2619
32. Christian H.C., Rolls N.J., and Morris J.F. Nongenomic actions of testosterone on a subset of lactotrophs in the male rat pituitary. Endocrinology 141 (2000) 3111-3119
33. Clarke R., van den Berg H.W., and Murphy R.F. Reduction of the membrane fluidity of human breast cancer cells by tamoxifen and 17 beta-estradiol. J. Natl. Cancer Inst. 82 (1990) 1702-1705
34. Compagnone N.A., and Mellon S.H. Neurosteroids: biosynthesis and function of these novel neuromodulators. Front. Neuroendocrinol. 21 (2000) 1-56
35. Cornil C., Foidart A., Minet A., and Balthazart J. Immunocytochemical localization of ionotropic glutamate receptors subunits in the adult quail forebrain. J. Comp. Neurol. 428 (2000) 577-608
36. Costarella C.E., Stallone J.N., Rutecki G.W., and Whittier F.C. Testosterone causes direct relaxation of rat thoracic aorta. J. Pharmacol. Exp. Ther. 277 (1996) 34-39
37. Couchourel D., Leclerc M., Filep J., and Brunette M.G. Testosterone enhances calcium reabsorption by the kidney. Mol. Cell. Endocrinol. 222 (2004) 71-81
38. Crews C.M., and Erikson R.L. Extracellular signals and reversible protein phosphorylation: what to Mek of it all. Cell 74 (1993) 215-217
39. Cross T.G., Scheel-Toellner D., Henriquez N.V., Deacon E., Salmon M., and Lord J.M. Serine/threonine protein kinases and apoptosis. Exp. Cell Res. 256 (2000) 34-41
40. Cruzalegui F.H., and Bading H. Calcium-regulated protein kinase cascades and their transcription factor targets. Cell Mol. Life Sci. 57 (2000) 402-410
41. Deenadayalu V.P., White R.E., Stallone J.N., Gao X., and Garcia A.J. Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) H1720-H1727
42. 2+-stimulated ATPase and lipid fluidity of synaptosomal plasma membranes from dog and rabbit brain. Comp. Biochem. Physiol. B 89 (1988) 585-594
43. Dolmetsch R.E., Xu K., and Lewis R.S. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392 (1998) 933-936
44. Duell P.B., and Bierman E.L. The relationship between sex hormones and high-density lipoprotein cholesterol levels in healthy adult men. Arch. Intern. Med. 150 (1990) 2317-2320
45. Duval D., Durant S., and Homo-Delarche F. Non-genomic effects of steroids. Interactions of steroid molecules with membrane structures and functions. Biochim. Biophys. Acta 737 (1983) 409-442
46. Edinger K.L., and Frye C.A. Androgens' effects to enhance learning may be mediated in part through actions at estrogen receptor-beta in the hippocampus. Neurobiol. Learn. Mem. 87 (2007) 78-85
47. English K.M., Jones R.D., Jones T.H., Morice A.H., and Channer K.S. Testosterone acts as a coronary vasodilator by a calcium antagonistic action. J. Endocrinol. Invest. 25 (2002) 455-458
48. English K.M., Mandour O., Steeds R.P., Diver M.J., Jones T.H., and Channer K.S. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur. Heart J. 21 (2000) 890-894
49. English K.M., Steeds R., Jones T.H., and Channer K.S. Testosterone and coronary heart disease: is there a link?. Qjm 90 (1997) 787-791
50. 2+ sparks: acute actions antagonize chronic effects. Cell Calcium 41 (2007) 467-477
51. + channels in the cardiac mitochondrial inner membrane. Circulation 110 (2004) 3100-3107
52. Estrada M., Espinosa A., Muller M., and Jaimovich E. Testosterone stimulates intracellular calcium release and mitogen-activated protein kinases via a G protein-coupled receptor in skeletal muscle cells. Endocrinology 144 (2003) 3586-3597
53. Estrada M., Liberona J.L., Miranda M., and Jaimovich E. Aldosterone- and testosterone-mediated intracellular calcium response in skeletal muscle cell cultures. Am. J. Physiol. Endocrinol. Metab. 279 (2000) E132-E139
54. 2+ oscillations induced by testosterone enhance neurite outgrowth. J. Cell Sci. 119 (2006) 733-743
55. Falkenstein E., Norman A.W., and Wehling M. Mannheim classification of nongenomically initiated (rapid) steroid action(s). J. Clin. Endocrinol. Metab. 85 (2000) 2072-2075
56. Falkenstein E., Tillmann H.C., Christ M., Feuring M., and Wehling M. Multiple actions of steroid hormones-a focus on rapid, nongenomic effects. Pharmacol. Rev. 52 (2000) 513-556
57. Farnsworth W.E. Na+, K(+)-ATPase: the actual androgen receptor of the prostate?. Med. Hypotheses 41 (1993) 358-362
58. Fernandez-Guasti A., and Martinez-Mota L. Anxiolytic-like actions of testosterone in the burying behavior test: role of androgen and GABA-benzodiazepine receptors. Psychoneuroendocrinology 30 (2005) 762-770
59. Fix C., Jordan C., Cano P., and Walker W.H. Testosterone activates mitogen-activated protein kinase and the cAMP response element binding protein transcription factor in Sertoli cells. Proc. Natl. Acad. Sci. USA 101 (2004) 10919-10924
60. Fortunati N. Sex hormone-binding globulin: not only a transport protein. What news is around the corner?. J. Endocrinol. Invest. 22 (1999) 223-234
61. Fortunati N., Fissore F., Fazzari A., Becchis M., Comba A., Catalano M.G., Berta L., and Frairia R. Sex steroid binding protein exerts a negative control on estradiol action in MCF-7 cells (human breast cancer) through cyclic adenosine 3′,5′-monophosphate and protein kinase A. Endocrinology 137 (1996) 686-692
62. Frairia R., Fortunati N., Berta L., Fazzari A., Fissore F., and Gaidano G. Sex steroid binding protein (SBP) receptors in estrogen sensitive tissues. J. Steroid Biochem. Mol. Biol. 40 (1991) 805-812
63. Frairia R., Fortunati N., Revelli A., Guidetti D., Cavaglia S., and Massobrio M. Binding of sex steroid binding protein to plasma membranes of human testis. J. Steroid Biochem. Mol. Biol. 51 (1994) 319-322
64. Fraser C.L., and Swanson R.A. Female sex hormones inhibit volume regulation in rat brain astrocyte culture. Am. J. Physiol. 267 (1994) C909-C914
65. Gatson J.W., Kaur P., and Singh M. Dihydrotestosterone differentially modulates the mitogen-activated protein kinase and the phosphoinositide 3-kinase/Akt pathways through the nuclear and novel membrane androgen receptor in C6 cells. Endocrinology 147 (2006) 2028-2034
66. Gatson J.W., and Singh M. Activation of a membrane-associated androgen receptor promotes cell death in primary cortical astrocytes. Endocrinology 148 (2007) 2458-2464
67. Gioeli D., Ficarro S.B., Kwiek J.J., Aaronson D., Hancock M., Catling A.D., White F.M., Christian R.E., Settlage R.E., Shabanowitz J., Hunt D.F., and Weber M.J. Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. J. Biol. Chem. 277 (2002) 29304-29314
68. Golden K.L., Marsh J.D., and Jiang Y. Testosterone regulates mRNA levels of calcium regulatory proteins in cardiac myocytes. Horm. Metab. Res. 36 (2004) 197-202
69. Gorczynska E., and Handelsman D.J. Androgens rapidly increase the cytosolic calcium concentration in Sertoli cells. Endocrinology 136 (1995) 2052-2059
70. Grishkovskaya I., Avvakumov G.V., Sklenar G., Dales D., Hammond G.L., and Muller Y.A. Crystal structure of human sex hormone-binding globulin: steroid transport by a laminin G-like domain. EMBO J. 19 (2000) 504-512
71. Gueant J.L., Fremont S., Felden F., Nicolas J.P., Gerard A., Leheup B., Gerard H., and Grignon G. Evidence that androgen-binding protein endocytosis in vitro is receptor mediated in principal cells of the rat epididymis. J. Mol. Endocrinol. 7 (1991) 113-122
72. Guo Z., Benten W.P., Krucken J., and Wunderlich F. Nongenomic testosterone calcium signaling. Genotropic actions in androgen receptor-free macrophages. J. Biol. Chem. 277 (2002) 29600-29607
73. Gupte S.A., Tateyama M., Okada T., Oka M., and Ochi R. Epiandrosterone, a metabolite of testosterone precursor, blocks L-type calcium channels of ventricular myocytes and inhibits myocardial contractility. J. Mol. Cell. Cardiol. 34 (2002) 679-688
74. Hak A.E., Witteman J.C., de Jong F.H., Geerlings M.I., Hofman A., and Pols H.A. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J. Clin. Endocrinol. Metab. 87 (2002) 3632-3639
75. 2+ channels in A7r5 cells by physiological levels of testosterone. Endocrinology 147 (2006) 2675-2680
76. Hanke H., Lenz C., Hess B., Spindler K.D., and Weidemann W. Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall. Circulation 103 (2001) 1382-1385
77. Harrison N.L., and Simmonds M.A. Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Res. 323 (1984) 287-292
78. He B., Kemppainen J.A., Voegel J.J., Gronemeyer H., and Wilson E.M. Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain. J. Biol. Chem. 274 (1999) 37219-37225
79. Heinlein C.A., and Chang C. The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol. Endocrinol. 16 (2002) 2181-2187
80. Henderson L.P. Steroid modulation of GABA(A) receptor-mediated transmission in the hypothalamus: effects on reproductive function. Neuropharmacology 52 (2007) 1439-1453
81. Herbert Z., Gothe S., Caldwell J.D., Bernstein H.G., Melle C., von Eggeling F., Lewis J., and Jirikowski G.F. Identification of sex hormone-binding globulin in the human hypothalamus. Neuroendocrinology 81 (2005) 287-293
82. Hitosugi T., Sasaki K., Sato M., Suzuki Y., and Umezawa Y. Epidermal growth factor directs sex-specific steroid signaling through Src activation. J. Biol. Chem. 282 (2007) 10697-10706
83. Honda H., Unemoto T., and Kogo H. Different mechanisms for testosterone-induced relaxation of aorta between normotensive and spontaneously hypertensive rats. Hypertension 34 (1999) 1232-1236
84. Hosie A.M., Wilkins M.E., da Silva H.M., and Smart T.G. Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature 444 (2006) 486-489
85. Hromadova M., Hacik T., Malatinsky E., and Riecansky I. Alterations of lipid metabolism in men with hypotestosteronemia. Horm. Metab. Res. 23 (1991) 392-394
86. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., and Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280 (1998) 605-613
87. Hutchison S.J., Browne A.E., Ko E., Chou T.M., Zellner C., Komesaroff P.A., Chatterjee K., and Sudhir K. Dehydroepiandrosterone sulfate induces acute vasodilation of porcine coronary arteries in vitro and in vivo. J. Cardiovasc. Pharmacol. 46 (2005) 325-332
88. Improta-Brears T., Whorton A.R., Codazzi F., York J.D., Meyer T., and McDonnell D.P. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc. Natl. Acad. Sci. USA 96 (1999) 4686-4691
89. Jacobus A.P., Rodrigues D.O., Borba P.F., Loss E.S., and Wassermann G.F. Isoproterenol opens K+(ATP) channels via a beta2-adrenoceptor-linked mechanism in Sertoli cells from immature rats. Horm. Metab. Res. 37 (2005) 198-204
90. Jenster G., de Ruiter P.E., van der Korput H.A., Kuiper G.G., Trapman J., and Brinkmann A.O. Changes in the abundance of androgen receptor isotypes: effects of ligand treatment, glutamine-stretch variation, and mutation of putative phosphorylation sites. Biochemistry 33 (1994) 14064-14072
91. Jones R.D., English K.M., Pugh P.J., Morice A.H., Jones T.H., and Channer K.S. Pulmonary vasodilatory action of testosterone: evidence of a calcium antagonistic action. J. Cardiovasc. Pharmacol. 39 (2002) 814-823
92. Jones R.D., Hugh Jones T., and Channer K.S. The influence of testosterone upon vascular reactivity. Eur. J. Endocrinol. 151 (2004) 29-37
93. Kahn S.M., Hryb D.J., Nakhla A.M., Romas N.A., and Rosner W. Sex hormone-binding globulin is synthesized in target cells. J. Endocrinol. 175 (2002) 113-120
94. Kampa M., Papakonstanti E.A., Alexaki V.I., Hatzoglou A., Stournaras C., and Castanas E. The opioid agonist ethylketocyclazocine reverts the rapid, non-genomic effects of membrane testosterone receptors in the human prostate LNCaP cell line. Exp. Cell Res. 294 (2004) 434-445
95. Kang H.Y., Cho C.L., Huang K.L., Wang J.C., Hu Y.C., Lin H.K., Chang C., and Huang K.E. Nongenomic androgen activation of phosphatidylinositol 3-kinase/Akt signaling pathway in MC3T3-E1 osteoblasts. J. Bone Miner. Res. 19 (2004) 1181-1190
96. Kapoor D., Goodwin E., Channer K.S., and Jones T.H. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur. J. Endocrinol. 154 (2006) 899-906
97. Karila T.A., Karjalainen J.E., Mantysaari M.J., Viitasalo M.T., and Seppala T.A. Anabolic androgenic steroids produce dose-dependant increase in left ventricular mass in power atheletes, and this effect is potentiated by concomitant use of growth hormone. Int. J. Sports Med. 24 (2003) 337-343
98. Kasbohm E.A., Guo R., Yowell C.W., Bagchi G., Kelly P., Arora P., Casey P.J., and Daaka Y. Androgen receptor activation by G(s) signaling in prostate cancer cells. J. Biol. Chem. 280 (2005) 11583-11589
99. Kelly M.J., and Levin E.R. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol. Metab. 12 (2001) 152-156
100. Khaw K.T., and Barrett-Connor E. Blood pressure and endogenous testosterone in men: an inverse relationship. J. Hypertens. 6 (1988) 329-332
101. Khaw K.T., and Barrett-Connor E. Endogenous sex hormones, high density lipoprotein cholesterol, and other lipoprotein fractions in men. Arterioscler. Thromb. 11 (1991) 489-494
102. Kim J., Jia L., Stallcup M.R., and Coetzee G.A. The role of protein kinase A pathway and cAMP responsive element-binding protein in androgen receptor-mediated transcription at the prostate-specific antigen locus. J. Mol. Endocrinol. 34 (2005) 107-118
103. Koenig H., Fan C.C., Goldstone A.D., Lu C.Y., and Trout J.J. Polyamines mediate androgenic stimulation of calcium fluxes and membrane transport in rat heart myocytes. Circ. Res. 64 (1989) 415-426
104. Koenig H., Goldstone A., and Lu C.Y. Testosterone induces a rapid stimulation of endocytosis, amino acid and hexose transport in mouse kidney cortex. Biochem. Biophys. Res. Commun. 106 (1982) 346-353
105. Kontoleon P.E., Anastasiou-Nana M.I., Papapetrou P.D., Alexopoulos G., Ktenas V., Rapti A.C., Tsagalou E.P., and Nanas J.N. Hormonal profile in patients with congestive heart failure. Int. J. Cardiol. 87 (2003) 179-183
106. Kousteni S., Bellido T., Plotkin L.I., O'Brien C.A., Bodenner D.L., Han L., Han K., DiGregorio G.B., Katzenellenbogen J.A., Katzenellenbogen B.S., Roberson P.K., Weinstein R.S., Jilka R.L., and Manolagas S.C. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104 (2001) 719-730
107. Kubli-Garfias C., Canchola E., Arauz-Contreras J., and Feria-Velasco A. Depressant effect of androgens on the cat brain electrical activity and its antagonism by ruthenium red. Neuroscience 7 (1982) 2777-2782
108. Kuhn-Velten W.N., and Kempfle M.A. Characterization of the hydrophobic interaction of steroids with endoplasmic reticulum membranes by quenching of 6,8(14)-bis-dehydro-17 alpha-hydroxyprogesterone fluorescence. Biochim. Biophys. Acta 1145 (1993) 185-190
109. Kuiper G.G., de Ruiter P.E., Grootegoed J.A., and Brinkmann A.O. Synthesis and post-translational modification of the androgen receptor in LNCaP cells. Mol. Cell. Endocrinol. 80 (1991) 65-73
110. Lee Y.F., Lin W.J., Huang J., Messing E.M., Chan F.L., Wilding G., and Chang C. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells. Cancer Res. 62 (2002) 6039-6044
111. Leite M.F., Thrower E.C., Echevarria W., Koulen P., Hirata K., Bennett A.M., Ehrlich B.E., and Nathanson M.H. Nuclear and cytosolic calcium are regulated independently. Proc. Natl. Acad. Sci. USA 100 (2003) 2975-2980
112. Leung G.P., Cheng-Chew S.B., and Wong P.Y. Nongenomic effect of testosterone on chloride secretion in cultured rat efferent duct epithelia. Am. J. Physiol. Cell Physiol. 280 (2001) C1160-C1167
113. 2+ spike frequency can optimize gene expression. Nature 392 (1998) 936-941
114. Lieberherr M., and Grosse B. Androgens increase intracellular calcium concentration and inositol 1,4,5-trisphosphate and diacylglycerol formation via a pertussis toxin-sensitive G-protein. J. Biol. Chem. 269 (1994) 7217-7223
115. Lieberherr M., Grosse B., Kachkache M., and Balsan S. Cell signaling and estrogens in female rat osteoblasts: a possible involvement of unconventional nonnuclear receptors. J. Bone Miner. Res. 8 (1993) 1365-1376
116. Liu X., Marengere L.E., Koch C.A., and Pawson T. The v-Src SH3 domain binds phosphatidylinositol 3′-kinase. Mol. Cell. Biol. 13 (1993) 5225-5232
117. Liu X.K., Katchman A., Whitfield B.H., Wan G., Janowski E.M., Woosley R.L., and Ebert S.N. In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rectifier potassium currents in orchiectomized male rabbits. Cardiovasc. Res. 57 (2003) 28-36
118. Loss E.S., Jacobsen M., Costa Z.S., Jacobus A.P., Borelli F., and Wassermann G.F. Testosterone modulates K(+)ATP channels in Sertoli cell membrane via the PLC-PIP2 pathway. Horm. Metab. Res. 36 (2004) 519-525
119. Lu M.L., Schneider M.C., Zheng Y., Zhang X., and Richie J.P. Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J. Biol. Chem. 276 (2001) 13442-13451
120. Lutz L.B., Jamnongjit M., Yang W.H., Jahani D., Gill A., and Hammes S.R. Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands. Mol. Endocrinol. 17 (2003) 1106-1116
121. Lyng F.M., Jones G.R., and Rommerts F.F. Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations. Biol. Reprod. 63 (2000) 736-747
122. MacGregor G.G., Dong K., Vanoye C.G., Tang L., Giebisch G., and Hebert S.C. Nucleotides and phospholipids compete for binding to the C terminus of KATP channels. Proc. Natl. Acad. Sci. USA 99 (2002) 2726-2731
123. Machelon V., Nome F., and Tesarik J. Nongenomic effects of androstenedione on human granulosa luteinizing cells. J. Clin. Endocrinol. Metab. 83 (1998) 263-269
124. Mainwaring W.I. The mechanism of action of androgens. Monogr. Endocrinol. 10 (1977) 1-178
125. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., and Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232 (1986) 1004-1007
126. Malkin C.J., Jones R.D., Jones T.H., and Channer K.S. Effect of testosterone on ex vivo vascular reactivity in man. Clin. Sci. (Lond.) 111 (2006) 265-274
127. Malkin C.J., Pugh P.J., Jones T.H., and Channer K.S. Testosterone for secondary prevention in men with ischaemic heart disease?. Qjm 96 (2003) 521-529
128. Malkin C.J., Pugh P.J., Morris P.D., Kerry K.E., Jones R.D., Jones T.H., and Channer K.S. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart 90 (2004) 871-876
129. Marostica E., Avellar M.C., and Porto C.S. Effects of testosterone on muscarinic acetylcholine receptors in the rat epididymis. Life Sci. 77 (2005) 656-669
130. Marsh J.D., Lehmann M.H., Ritchie R.H., Gwathmey J.K., Green G.E., and Schiebinger R.J. Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 98 (1998) 256-261
131. Mellon S.H., Griffin L.D., and Compagnone N.A. Biosynthesis and action of neurosteroids. Brain Res. Brain Res. Rev. 37 (2001) 3-12
132. Mellstrom B., and Naranjo J.R. Mechanisms of Ca(2+)-dependent transcription. Curr. Opin. Neurobiol. 11 (2001) 312-319
133. Mendel C.M. The free hormone hypothesis: a physiologically based mathematical model. Endocr. Rev. 10 (1989) 232-274
134. Messerli F.H., Garavaglia G.E., Schmieder R.E., Sundgaard-Riise K., Nunez B.D., and Amodeo C. Disparate cardiovascular findings in men and women with essential hypertension. Ann. Intern. Med. 107 (1987) 158-161
135. Michels G., Er F., Eicks M., Herzig S., and Hoppe U.C. Long-term and immediate effect of testosterone on single T-type calcium channel in neonatal rat cardiomyocytes. Endocrinology 147 (2006) 5160-5169
136. Michels G., and Moss S.J. GABAA receptors: properties and trafficking. Crit. Rev. Biochem. Mol. Biol. 42 (2007) 3-14
137. Migliaccio A., Castoria G., Di Domenico M., de Falco A., Bilancio A., Lombardi M., Barone M.V., Ametrano D., Zannini M.S., Abbondanza C., and Auricchio F. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J. 19 (2000) 5406-5417
138. Mishra S., Smolik S.M., Forte M.A., and Stork P.J. Ras-independent activation of ERK signaling via the torso receptor tyrosine kinase is mediated by Rap1. Curr. Biol. 15 (2005) 366-370
139. Mor A., and Philips M.R. Compartmentalized Ras/MAPK signaling. Annu. Rev. Immunol. 24 (2006) 771-800
140. Morrow A.L., Suzdak P.D., and Paul S.M. Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency. Eur. J. Pharmacol. 142 (1987) 483-485
141. Mukai H., Tsurugizawa T., Ogiue-Ikeda M., Murakami G., Hojo Y., Ishii H., Kimoto T., and Kawato S. Local neurosteroid production in the hippocampus: influence on synaptic plasticity of memory. Neuroendocrinology 84 (2006) 255-263
142. Nakhla A.M., Leonard J., Hryb D.J., and Rosner W. Sex hormone-binding globulin receptor signal transduction proceeds via a G protein. Steroids 64 (1999) 213-216
143. Nakhla A.M., Romas N.A., and Rosner W. Estradiol activates the prostate androgen receptor and prostate-specific antigen secretion through the intermediacy of sex hormone-binding globulin. J. Biol. Chem. 272 (1997) 6838-6841
144. Napoli R., Gibson L., Hirshman M.F., Boppart M.D., Dufresne S.D., Horton E.S., and Goodyear L.J. Epinephrine and insulin stimulate different mitogen-activated protein kinase signaling pathways in rat skeletal muscle. Diabetes 47 (1998) 1549-1554
145. Neves S.R., Ram P.T., and Iyengar R. G protein pathways. Science 296 (2002) 1636-1639
146. Okamoto T., Schlegel A., Scherer P.E., and Lisanti M.P. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273 (1998) 5419-5422
147. Papakonstanti E.A., Kampa M., Castanas E., and Stournaras C. A rapid, nongenomic, signaling pathway regulates the actin reorganization induced by activation of membrane testosterone receptors. Mol. Endocrinol. 17 (2003) 870-881
148. Paul S.M., and Purdy R.H. Neuroactive steroids. FASEB J. 6 (1992) 2311-2322
149. Perusquia M., Hernandez R., Morales M.A., Campos M.G., and Villalon C.M. Role of endothelium in the vasodilating effect of progestins and androgens on the rat thoracic aorta. Gen. Pharmacol. 27 (1996) 181-185
150. 2+ channels in the vasodilating effect of 5beta-dihydrotestosterone in rat aorta. Eur. J. Pharmacol. 371 (1999) 169-178
151. Peterziel H., Mink S., Schonert A., Becker M., Klocker H., and Cato A.C. Rapid signalling by androgen receptor in prostate cancer cells. Oncogene 18 (1999) 6322-6329
152. Pierce K.L., Premont R.T., and Lefkowitz R.J. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3 (2002) 639-650
153. Pluciennik F., Verrecchia F., Bastide B., Herve J.C., Joffre M., and Deleze J. Reversible interruption of gap junctional communication by testosterone propionate in cultured Sertoli cells and cardiac myocytes. J. Membr. Biol. 149 (1996) 169-177
154. Porto C.S., Lazari M.F., Abreu L.C., Bardin C.W., and Gunsalus G.L. Receptors for androgen-binding proteins: internalization and intracellular signalling. J. Steroid Biochem. Mol. Biol. 53 (1995) 561-565
155. Pugh P.J., Jones T.H., and Channer K.S. Acute haemodynamic effects of testosterone in men with chronic heart failure. Eur. Heart J. 24 (2003) 909-915
156. Reddy D.S. Anticonvulsant activity of the testosterone-derived neurosteroid 3alpha-androstanediol. Neuroreport 15 (2004) 515-518
157. Reddy D.S. Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3alpha-androstanediol and 17beta-estradiol. Neuroscience 129 (2004) 195-207
158. Revelli A., Massobrio M., and Tesarik J. Nongenomic actions of steroid hormones in reproductive tissues. Endocr. Rev. 19 (1998) 3-17
159. Reventos J., Sullivan P.M., Joseph D.R., and Gordon J.W. Tissue-specific expression of the rat androgen-binding protein/sex hormone-binding globulin gene in transgenic mice. Mol. Cell. Endocrinol. 96 (1993) 69-73
160. Ricote M., Garcia-Tunon I., Fraile B., Fernandez C., Aller P., Paniagua R., and Royuela M. P38 MAPK protects against TNF-alpha-provoked apoptosis in LNCaP prostatic cancer cells. Apoptosis 11 (2006) 1969-1975
161. Rosano G.M., Leonardo F., Pagnotta P., Pelliccia F., Panina G., Cerquetani E., della Monica P.L., Bonfigli B., Volpe M., and Chierchia S.L. Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation 99 (1999) 1666-1670
162. Rosner W. The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocr. Rev. 11 (1990) 80-91
163. Rosner W., Hryb D.J., Khan M.S., Nakhla A.M., and Romas N.A. Androgen and estrogen signaling at the cell membrane via G-proteins and cyclic adenosine monophosphate. Steroids 64 (1999) 100-106
164. Rosner W., Hryb D.J., Khan M.S., Nakhla A.M., and Romas N.A. Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane. J. Steroid Biochem. Mol. Biol. 69 (1999) 481-485
165. Ross E.M., and Gilman A.G. Biochemical properties of hormone-sensitive adenylate cyclase. Annu. Rev. Biochem. 49 (1980) 533-564
166. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A., Howard B.V., Johnson K.C., Kotchen J.M., and Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
167. Roy A.K., Lavrovsky Y., Song C.S., Chen S., Jung M.H., Velu N.K., Bi B.Y., and Chatterjee B. Regulation of androgen action. Vitam. Horm. 55 (1999) 309-352
168. Rubin J.M., Hidalgo A., Bordallo C., Cantabrana B., and Sanchez M. Positive inotropism induced by androgens in isolated left atrium of rat: evidence for a cAMP-dependent transcriptional mechanism. Life Sci. 65 (1999) 1035-1045
169. Sachs B.D., and Leipheimer R.E. Rapid effect of testosterone on striated muscle activity in rats. Neuroendocrinology 48 (1988) 453-458
170. Sadar M.D. Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways. J. Biol. Chem. 274 (1999) 7777-7783
171. Schock H.W., Herbert Z., Sigusch H., Figulla H.R., Jirikowski G.F., and Lotze U. Expression of androgen-binding protein (ABP) in human cardiac myocytes. Horm. Metab. Res. 38 (2006) 225-229
172. Schumacher M. Rapid membrane effects of steroid hormones: an emerging concept in neuroendocrinology. Trends Neurosci. 13 (1990) 359-362
173. Scragg J.L., Jones R.D., Channer K.S., Jones T.H., and Peers C. Testosterone is a potent inhibitor of L-type Ca(2+) channels. Biochem. Biophys. Res. Commun. 318 (2004) 503-506
174. Secades L., Cortina R., Velasco L., Bordallo J., Hidalgo A., and Sanchez M. Interaction of androgens with cardiotonic drugs in isolated left atrium of rat. Pharmacology 70 (2004) 118-122
175. 2+-dependent calcineurin signalling pathway. Nature 400 (1999) 576-581
176. Seyrek M., Yildiz O., Ulusoy H.B., and Yildirim V. Testosterone relaxes isolated human radial artery by potassium channel opening action. J. Pharmacol. Sci. 103 (2007) 309-316
177. Siiteri P.K., Murai J.T., Hammond G.L., Nisker J.A., Raymoure W.J., and Kuhn R.W. The serum transport of steroid hormones. Recent Prog. Horm. Res. 38 (1982) 457-510
178. Simoncini T., and Genazzani A.R. Non-genomic actions of sex steroid hormones. Eur. J. Endocrinol. 148 (2003) 281-292
179. Simoncini T., Hafezi-Moghadam A., Brazil D.P., Ley K., Chin W.W., and Liao J.K. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407 (2000) 538-541
180. Somjen D., Kohen F., Gayer B., Kulik T., Knoll E., and Stern N. Role of putative membrane receptors in the effect of androgens on human vascular cell growth. J. Endocrinol. 180 (2004) 97-106
181. Sprang S.R. G protein mechanisms: insights from structural analysis. Annu. Rev. Biochem. 66 (1997) 639-678
182. Stampfer M.J., Colditz G.A., Willett W.C., Manson J.E., Rosner B., Speizer F.E., and Hennekens C.H. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N. Engl. J. Med. 325 (1991) 756-762
183. Steinsapir J., Socci R., and Reinach P. Effects of androgen on intracellular calcium of LNCaP cells. Biochem. Biophys. Res. Commun. 179 (1991) 90-96
184. Stoffel E.C., Ulibarri C.M., and Craft R.M. Gonadal steroid hormone modulation of nociception, morphine antinociception and reproductive indices in male and female rats. Pain 103 (2003) 285-302
185. Stork P.J., and Dillon T.J. Multiple roles of Rap1 in hematopoietic cells: complementary versus antagonistic functions. Blood 106 (2005) 2952-2961
186. Stover D.R., Becker M., Liebetanz J., and Lydon N.B. Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and P85 alpha. J. Biol. Chem. 270 (1995) 15591-15597
187. Stumpf W.E. Steroid hormones and the cardiovascular system: direct actions of estradiol, progesterone, testosterone, gluco- and mineralcorticoids, and soltriol [vitamin D] on central nervous regulatory and peripheral tissues. Experientia 46 (1990) 13-25
188. Sumanasekera W.K., Zhao L., Ivanova M., Morgan D.D., Noisin E.L., Keynton R.S., and Klinge C.M. Effect of estradiol and dihydrotestosterone on hypergravity-induced MAPK signaling and occludin expression in human umbilical vein endothelial cells. Cell Tissue Res. 324 (2006) 243-253
189. Sun M., Yang L., Feldman R.I., Sun X.M., Bhalla K.N., Jove R., Nicosia S.V., and Cheng J.Q. Activation of phosphatidylinositol 3-kinase/Akt pathway by androgen through interaction of p85alpha, androgen receptor, and Src. J. Biol. Chem. 278 (2003) 42992-43000
190. Sun Y.H., Gao X., Tang Y.J., Xu C.L., and Wang L.H. Androgens induce increases in intracellular calcium via a G protein-coupled receptor in LNCaP prostate cancer cells. J. Androl. 27 (2006) 671-678
191. Szego C.M., and Davis J.S. Adenosine 3′,5′-monophosphate in rat uterus: acute elevation by estrogen. Proc. Natl. Acad. Sci. USA 58 (1967) 1711-1718
192. Taneja S.S., Ha S., Swenson N.K., Huang H.Y., Lee P., Melamed J., Shapiro E., Garabedian M.J., and Logan S.K. Cell-specific regulation of androgen receptor phosphorylation in vivo. J. Biol. Chem. 280 (2005) 40916-40924
193. Thompson P.D., Ahlberg A.W., Moyna N.M., Duncan B., Ferraro-Borgida M., White C.M., McGill C.C., and Heller G.V. Effect of intravenous testosterone on myocardial ischemia in men with coronary artery disease. Am. Heart J. 143 (2002) 249-256
194. Unni E., Sun S., Nan B., McPhaul M.J., Cheskis B., Mancini M.A., and Marcelli M. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Cancer Res. 64 (2004) 7156-7168
195. Van Bommel T., Marsen T., and Bojar H. Effects of high-dose medroxyprogesterone acetate and various other steroid hormones on plasma membrane lipid mobility in CAMA-1 mammary cancer cells. Anticancer Res. 7 (1987) 1217-1223
196. van den Beld A.W., Bots M.L., Janssen J.A., Pols H.A., Lamberts S.W., and Grobbee D.E. Endogenous hormones and carotid atherosclerosis in elderly men. Am. J. Epidemiol. 157 (2003) 25-31
197. Van Eynde A., Beullens M., Stalmans W., and Bollen M. Full activation of a nuclear species of protein phosphatase-1 by phosphorylation with protein kinase A and casein kinase-2. Biochem. J. 297 Pt 3 (1994) 447-449
198. Van Eynde A., Wera S., Beullens M., Torrekens S., Van Leuven F., Stalmans W., and Bollen M. Molecular cloning of NIPP-1, a nuclear inhibitor of protein phosphatase-1, reveals homology with polypeptides involved in RNA processing. J. Biol. Chem. 270 (1995) 28068-28074
199. van Laar J.H., Berrevoets C.A., Trapman J., Zegers N.D., and Brinkmann A.O. Hormone-dependent androgen receptor phosphorylation is accompanied by receptor transformation in human lymph node carcinoma of the prostate cells. J. Biol. Chem. 266 (1991) 3734-3738
200. van Laar J.H., Bolt-de Vries J., Zegers N.D., Trapman J., and Brinkmann A.O. Androgen receptor heterogeneity and phosphorylation in human LNCaP cells. Biochem. Biophys. Res. Commun. 166 (1990) 193-200
201. Vicencio J.M., Ibarra C., Estrada M., Chiong M., Soto D., Parra V., Diaz-Araya G., Jaimovich E., and Lavandero S. Testosterone induces an intracellular calcium increase by a nongenomic mechanism in cultured rat cardiac myocytes. Endocrinology 147 (2006) 1386-1395
202. Von Ledebur E.I., Almeida J.P., Loss E.S., and Wassermann G.F. Rapid effect of testosterone on rat Sertoli cell membrane potential. Relationship with K+ATP channels. Horm. Metab. Res. 34 (2002) 550-555
203. Webb C.M., Adamson D.L., de Zeigler D., and Collins P. Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. Am. J. Cardiol. 83 (1999) 437-439, A43
204. Wehling M. Specific, nongenomic actions of steroid hormones. Annu. Rev. Physiol. 59 (1997) 365-393
205. Wen Y., Hu M.C., Makino K., Spohn B., Bartholomeusz G., Yan D.H., and Hung M.C. HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway. Cancer Res. 60 (2000) 6841-6845
206. White S.A., Livingston F.S., and Mooney R. Androgens modulate NMDA receptor-mediated EPSCs in the zebra finch song system. J. Neurophysiol. 82 (1999) 2221-2234
207. Whiting K.P., Restall C.J., and Brain P.F. Steroid hormone-induced effects on membrane fluidity and their potential roles in non-genomic mechanisms. Life Sci. 67 (2000) 743-757
208. Williams M.R., Ling S., Dawood T., Hashimura K., Dai A., Li H., Liu J.P., Funder J.W., Sudhir K., and Komesaroff P.A. Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs. J. Clin. Endocrinol. Metab. 87 (2002) 176-181
209. Willmer E.N. Steroids and cell surfaces. Biol. Rev. Camb. Philos. Soc. 36 (1961) 368-398
210. Wingard D.L., Suarez L., and Barrett-Connor E. The sex differential in mortality from all causes and ischemic heart disease. Am. J. Epidemiol. 117 (1983) 165-172
211. Xu T., Shen Y., Pink H., Triantafillou J., Stimpson S.A., Turnbull P., and Han B. Phosphorylation of p70s6 kinase is implicated in androgen-induced levator ani muscle anabolism in castrated rats. J. Steroid Biochem. Mol. Biol. 92 (2004) 447-454
212. Yamada Y. Effects of testosterone on unit activity in rat hypothalamus and septum. Brain Res. 172 (1979) 165-168
213. Yoon S., and Seger R. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24 (2006) 21-44
214. Yue P., Chatterjee K., Beale C., Poole-Wilson P.A., and Collins P. Testosterone relaxes rabbit coronary arteries and aorta. Circulation 91 (1995) 1154-1160
215. Zagar Y., Chaumaz G., and Lieberherr M. Signaling cross-talk from Gbeta4 subunit to Elk-1 in the rapid action of androgens. J. Biol. Chem. 279 (2004) 2403-2413
216. Zhang L., Li B., Ma W., Barker J.L., Chang Y.H., Zhao W., and Rubinow D.R. Dehydroepiandrosterone (DHEA) and its sulfated derivative (DHEAS) regulate apoptosis during neurogenesis by triggering the Akt signaling pathway in opposing ways. Brain Res. Mol. Brain Res. 98 (2002) 58-66
217. Zhou Z.X., Kemppainen J.A., and Wilson E.M. Identification of three proline-directed phosphorylation sites in the human androgen receptor. Mol. Endocrinol. 9 (1995) 605-615
218. Zhu X., Li H., Liu J.P., and Funder J.W. Androgen stimulates mitogen-activated protein kinase in human breast cancer cells. Mol. Cell. Endocrinol. 152 (1999) 199-206
219. Zhu Z., Becklin R.R., Desiderio D.M., and Dalton J.T. Identification of a novel phosphorylation site in human androgen receptor by mass spectrometry. Biochem. Biophys. Res. Commun. 284 (2001) 836-844
220. Zinder O., and Dar D.E. Neuroactive steroids: their mechanism of action and their function in the stress response. Acta Physiol. Scand. 167 (1999) 181-188
221. 2+-ATPase activity. Biochim. Biophys. Acta 1437 (1999) 257-264